Notizie dei mercati

Neurocrine Biosciences, Inc.: RBC Capital Markets ribadisce il giudizio Neutral

This content has been archived. It may no longer be relevant

Neurocrine Biosciences, Inc.: RBC Capital Markets ribadisce il giudizio Neutral

Neurocrine Biosciences Capital


FIMA2854# 2022-09-02T15:01:15+02:00

Show More